Ditte Hansenمشاهده پروفایل
استاد بالینی
- Chronic Kidney Disease – Mineral and Bone Disorder (CKD-MBD)
- Diabetic nephropathy
- Renal osteodystrophy
- +۳ مورد دیگر
Ditte Hansen serves as a Clinical Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. She holds a dual appointment, being employed both by the Capital Region of Denmark and the University of Copenhagen, and is affiliated with Herlev and Gentofte Hospital's Department of Nephrology. Her academic work bridges clinical practice and research in nephrology, with a specific focus on mineral and bone disorders related to kidney disease. Dr. Hansen's research interests center on Chronic Kidney Disease – Mineral and Bone Disorder (CKD-MBD), diabetic nephropathy, renal osteodystrophy, and randomized clinical trials. Her work encompasses clinical studies, translational research, and bone biopsy analysis. She leads or participates in significant research initiatives including the Copenhagen-MBD group and PRIMETIME, which focuses on precision medicine based on kidney tissue molecular interrogation in diabetic nephropathy. Her research program investigates the diagnosis of renal osteodystrophy, pathophysiology of disturbances in mineral homeostasis in kidney disease, and treatment approaches for CKD-MBD. Analysis of Dr. Hansen's recent publications reveals a strong emphasis on clinical trial methodology and translational research in nephrology. Her work spans multiple sub-disciplines including cardiovascular complications of kidney disease, bone mineral disorders, diagnostic methodologies, and innovative treatment approaches. The pattern shows increasing collaboration across European institutions and a focus on generating evidence-based guidelines for clinical practice. Dr. Hansen actively contributes to multidisciplinary research teams focused on kidney disease complications. Her work with the European Renal Osteodystrophy initiative demonstrates international collaboration to establish consensus on diagnostic criteria and treatment approaches for renal bone disease. Through her dual appointment, she effectively bridges the gap between academic research and clinical practice, ensuring that scientific discoveries translate directly to patient care improvements.







